Q3 2023 · 13F-HR
Novo Holdings A/Sholdings as filed
Filed 2023-11-14 · accession 0000950123-23-010600
$1.35B
Reported value
40
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 11271J107 | BN | BROOKFIELD CORP | $121.3M | 8.97% | 3,880,230 | Common | SOLE |
| N07059210 | ASML | ASML HOLDING N V | $116.4M | 8.60% | 197,760 | Common | SOLE |
| 79466L302 | CRM | SALESFORCE.COM, INC. | $107.6M | 7.95% | 530,500 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $92.0M | 6.80% | 3,377,768 | Common | SOLE |
| 51655R101 | — | LANZATECH GLOBAL INC | $73.9M | 5.46% | 15,814,845 | Common | SOLE |
| 12685J105 | CABO | CABLE ONE INC | $72.9M | 5.39% | 118,403 | Common | SOLE |
| 874039100 | TSM | TAIWAN SEMICONDUCTOR MFG LTD | $61.8M | 4.56% | 710,780 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE, INC. | $51.2M | 3.79% | 1,090,772 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $47.4M | 3.50% | 1,500,000 | Common | SOLE |
| 01609W102 | BABA | ALIBABA GROUP HLDG LTD | $43.4M | 3.21% | 500,827 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $43.1M | 3.18% | 845,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX, INC. | $38.6M | 2.85% | 1,075,000 | Common | SOLE |
| 037833100 | AAPL | APPLE INC | $37.9M | 2.80% | 221,460 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $35.4M | 2.62% | 400,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $34.8M | 2.57% | 6,071,703 | Common | SOLE |
| 81181C104 | — | SEAGEN INC. | $33.9M | 2.51% | 159,986 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $33.8M | 2.50% | 1,339,304 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $32.7M | 2.42% | 1,100,000 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $27.7M | 2.05% | 1,329,325 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $26.4M | 1.95% | 525,000 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $25.5M | 1.88% | 2,095,900 | Common | SOLE |
| 75974E103 | — | RENEO PHARMACEUTICALS INC | $25.3M | 1.87% | 3,330,377 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $23.4M | 1.73% | 1,566,521 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $21.0M | 1.55% | 118,383 | Common | SOLE |
| 113004105 | BAM | BROOKFIELD ASSET MANAGMT LTD | $20.9M | 1.55% | 627,207 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $20.5M | 1.52% | 1,001,000 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $15.3M | 1.13% | 1,200,000 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $15.2M | 1.12% | 6,722,336 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $11.9M | 0.88% | 60,000 | Common | SOLE |
| 449778109 | IOBTQ | IO BIOTECH INC | $8.1M | 0.60% | 5,747,067 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $7.4M | 0.54% | 2,187,999 | Common | SOLE |
| 00288U106 | ABCL | ABCELLERA BIOLOGICS INC | $5.2M | 0.38% | 1,126,915 | Common | SOLE |
| 82710M100 | SILKUSD | SILK RD MED INC | $5.0M | 0.37% | 333,884 | Common | SOLE |
| 89455T109 | TMCI | TREACE MED CONCEPTS INC | $4.7M | 0.35% | 360,000 | Common | SOLE |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $3.5M | 0.26% | 2,400,000 | Common | SOLE |
| 57142B104 | MQ | MARQETA INC | $2.6M | 0.20% | 441,558 | Common | SOLE |
| 23284P103 | — | CYTEIR THERAPEUTICS INC | $1.9M | 0.14% | 676,379 | Common | SOLE |
| 36322Q107 | GLTOUSD | GALECTO INC | $1.8M | 0.13% | 2,497,791 | Common | SOLE |
| 49705R105 | KNTEUSD | KINNATE BIOPHARMA INC | $1.1M | 0.08% | 815,707 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $567,371 | 0.04% | 468,902 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.